Alexion Pharmaceuticals Gross Margin 2006-2019 | ALXN

Current and historical gross margin for Alexion Pharmaceuticals (ALXN) over the last 10 years. The current gross profit margin for Alexion Pharmaceuticals as of June 30, 2019 is %.
Alexion Pharmaceuticals Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2019-06-30 $4.50B $4.13B 91.73%
2019-03-31 $4.34B $3.97B 91.52%
2018-12-31 $4.13B $3.76B 90.92%
2018-09-30 $3.91B $3.49B 89.19%
2018-06-30 $3.75B $3.26B 86.94%
2018-03-31 $3.61B $3.14B 86.77%
2017-12-31 $3.55B $3.10B 87.19%
2017-09-30 $3.47B $3.10B 89.12%
2017-06-30 $3.41B $3.12B 91.44%
2017-03-31 $3.25B $2.99B 91.76%
2016-12-31 $3.08B $2.83B 91.63%
2016-09-30 $2.95B $2.71B 91.60%
2016-06-30 $2.82B $2.59B 91.81%
2016-03-31 $2.71B $2.48B 91.76%
2015-12-31 $2.60B $2.37B 91.05%
2015-09-30 $2.50B $2.28B 91.01%
2015-06-30 $2.39B $2.17B 90.67%
2015-03-31 $2.27B $2.06B 90.74%
2014-12-31 $2.23B $2.06B 92.21%
2014-09-30 $2.08B $1.90B 91.52%
2014-06-30 $1.92B $1.75B 90.89%
2014-03-31 $1.78B $1.60B 90.16%
2013-12-31 $1.55B $1.37B 88.59%
2013-09-30 $1.43B $1.27B 88.88%
2013-06-30 $1.32B $1.24B 93.35%
2013-03-31 $1.23B $1.15B 93.41%
2012-12-31 $1.14B $1.06B 93.39%
2012-09-30 $1.04B $0.97B 93.28%
2012-06-30 $0.95B $0.84B 88.13%
2012-03-31 $0.86B $0.76B 88.06%
2011-12-31 $0.78B $0.69B 88.14%
2011-09-30 $0.71B $0.63B 88.20%
2011-06-30 $0.65B $0.57B 88.00%
2011-03-31 $0.59B $0.52B 88.14%
2010-12-31 $0.54B $0.48B 88.01%
2010-09-30 $0.50B $0.44B 88.33%
2010-06-30 $0.46B $0.41B 88.43%
2010-03-31 $0.42B $0.38B 88.44%
2009-12-31 $0.39B $0.34B 88.37%
2009-09-30 $0.35B $0.32B 89.24%
2009-06-30 $0.33B $0.29B 89.30%
2009-03-31 $0.30B $0.26B 88.81%
2008-12-31 $0.26B $0.23B 88.85%
2008-09-30 $0.22B $0.19B 87.56%
2008-06-30 $0.16B $0.14B 87.65%
2008-03-31 $0.11B $0.10B 88.39%
2007-12-31 $0.07B $0.07B 90.28%
2007-09-30 $0.04B $0.04B 92.11%
2007-06-30 $0.02B $0.02B 93.75%
2007-03-31 $0.01B $0.01B 100.00%
2006-12-31 $0.00B $0.00B 100.00%
2006-06-30 $0.00B $0.00B 100.00%
2006-03-31 $0.00B $0.00B 100.00%
2005-10-31 $0.00B 0 nan%
2005-09-30 $0.00B 0 nan%
2005-07-31 $0.00B $0.00B 100.00%
2005-06-30 $0.00B $0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $22.723B $4.131B
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.673B 13.86
Gilead Sciences (GILD) United States $81.699B 10.03
CSL (CSLLY) Australia $74.842B 0.00
Celgene (CELG) United States $71.151B 11.01
Illumina (ILMN) United States $45.616B 53.59
Vertex Pharmaceuticals (VRTX) United States $44.619B 48.22
Biogen (BIIB) United States $41.641B 7.40
Regeneron Pharmaceuticals (REGN) United States $33.547B 15.23
Actelion (ALIOF) Switzerland $29.891B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Incyte (INCY) United States $16.659B 49.03
Seattle Genetics (SGEN) United States $13.329B 0.00
Exact Sciences (EXAS) United States $12.282B 0.00
Genmab (GNMSF) Denmark $12.097B 67.86
BioMarin Pharmaceutical (BMRN) United States $12.067B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.801B 0.00
Galapagos (GLPG) Belgium $8.558B 0.00
Bio-Techne Corp (TECH) United States $7.583B 52.38
Sarepta Therapeutics (SRPT) United States $6.371B 0.00
QIAGEN (QGEN) Netherlands $6.143B 20.18
Guardant Health (GH) United States $5.967B 0.00
BeiGene (BGNE) Cayman Islands $5.817B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.704B 0.00
Amarin (AMRN) Ireland $5.519B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.086B 12.93
Exelixis (EXEL) United States $4.962B 12.90
Bluebird Bio (BLUE) United States $4.907B 0.00
Moderna (MRNA) United States $4.599B 0.00
China Biologic Products (CBPO) China $4.526B 28.25
ARGENX SE-ADR (ARGX) Netherlands $4.253B 0.00
Medicines (MDCO) United States $4.141B 0.00
Ascendis Pharma (ASND) Denmark $3.986B 0.00
Repligen (RGEN) United States $3.981B 77.25
Spark Therapeutics (ONCE) United States $3.797B 0.00
Blueprint Medicines (BPMC) United States $3.534B 0.00
MorphoSys AG (MOR) Germany $3.402B 0.00
Reata Pharmaceuticals (RETA) United States $3.028B 0.00
Mirati Therapeutics (MRTX) United States $3.024B 0.00
Alkermes (ALKS) Ireland $2.810B 0.00
Emergent Biosolutions (EBS) United States $2.707B 40.67
Immunomedics (IMMU) United States $2.699B 0.00
Genomic Health (GHDX) United States $2.601B 48.78
Genmab (GMAB) Denmark $2.547B 0.00
MyoKardia (MYOK) United States $2.458B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.358B 5.07
Halozyme Therapeutics (HALO) United States $2.297B 0.00
RA PHARMCTL INC (RARX) United States $2.207B 0.00
Myriad Genetics (MYGN) United States $2.192B 23.01
Acceleron Pharma (XLRN) United States $2.121B 0.00
NeoGenomics (NEO) United States $2.046B 109.44
Amicus Therapeutics (FOLD) United States $2.022B 0.00
Cambrex (CBM) United States $2.010B 25.41
CRISPR Therapeutics AG (CRSP) Switzerland $2.005B 0.00
Ligand Pharmaceuticals (LGND) United States $1.991B 25.17
Intercept Pharmaceuticals (ICPT) United States $1.989B 0.00
Zai Lab (ZLAB) China $1.942B 0.00
Akcea Therapeutics (AKCA) United States $1.819B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.586B 0.00
UniQure (QURE) Netherlands $1.586B 0.00
Insmed (INSM) United States $1.522B 0.00
Denali Therapeutics (DNLI) United States $1.437B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.401B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.326B 0.00
REGENXBIO (RGNX) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.255B 0.00
Zymeworks (ZYME) Canada $1.101B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.093B 0.00
Innoviva (INVA) United States $1.084B 3.13
Alector (ALEC) United States $1.010B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.003B 0.00
Editas Medicine (EDIT) United States $0.982B 0.00
Sangamo Therapeutics (SGMO) United States $0.929B 0.00
Fate Therapeutics (FATE) United States $0.924B 0.00
AnaptysBio (ANAB) United States $0.916B 0.00
Epizyme (EPZM) United States $0.911B 0.00
ANI Pharmaceuticals (ANIP) United States $0.860B 14.36
Athenex (ATNX) United States $0.837B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.785B 27.78
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Codexis (CDXS) United States $0.777B 0.00
Cara Therapeutics (CARA) United States $0.755B 0.00
Twist Bioscience (TWST) United States $0.746B 0.00
Zealand Pharma (ZEAL) Denmark $0.738B 8.28
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Principia Biopharma (PRNB) United States $0.705B 364.63
ZIOPHARM Oncology Inc (ZIOP) United States $0.697B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.689B 24.89
WAVE Life Sciences (WVE) Singapore $0.681B 0.00
Cytokineticsorporated (CYTK) United States $0.654B 0.00
Vericel (VCEL) United States $0.636B 0.00
Mesoblast (MESO) Australia $0.620B 0.00
Revance Therapeutics (RVNC) United States $0.618B 0.00
Heska (HSKA) United States $0.570B 73.87
Arvinas (ARVN) United States $0.562B 0.00
GENFIT S.A (GNFT) France $0.550B 0.00
MiMedx (MDXG) United States $0.550B 0.00
Intellia Therapeutics (NTLA) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.496B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.488B 0.00
PHARMA MAR SA (PHMMF) Spain $0.482B 0.00
Retrophin (RTRX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.430B 0.00
Intra-Cellular Therapies (ITCI) United States $0.429B 0.00
DBV Technologies S.A (DBVT) France $0.427B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.424B 0.00
Cellectis S.A (CLLS) France $0.413B 0.00
Adverum Biotechnologies (ADVM) United States $0.393B 0.00
Stemline Therapeutics (STML) United States $0.382B 0.00
Syros Pharmaceuticals (SYRS) United States $0.370B 0.00
Agenus (AGEN) United States $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.368B 0.00
Arcus Biosciences (RCUS) United States $0.367B 0.00
Bellus Health (BLU) Canada $0.366B 0.00
Merus (MRUS) Netherlands $0.361B 0.00
Precision BioSciences (DTIL) United States $0.349B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.344B 0.00
Kadmon Holdings (KDMN) United States $0.337B 0.00
AC Immune SA (ACIU) Switzerland $0.335B 24.80
CytomX Therapeutics (CTMX) United States $0.320B 0.00
Prothena (PRTA) Ireland $0.311B 0.00
Gritstone Oncology (GRTS) United States $0.307B 0.00
Protagonist Therapeutics (PTGX) United States $0.300B 0.00
Avid Bioservices (CDMO) United States $0.298B 0.00
Theratechnologies (THTX) Canada $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Pfenex (PFNX) United States $0.283B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Geron (GERN) United States $0.275B 0.00
Cel-Sci (CVM) United States $0.275B 0.00
Kindred Biosciences (KIN) United States $0.273B 0.00
PDL BioPharma (PDLI) United States $0.273B 7.03
Scholar Rock Holding (SRRK) United States $0.269B 0.00
Dynavax Technologies (DVAX) United States $0.266B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Puma Biotechnology (PBYI) United States $0.264B 0.00
MannKind (MNKD) United States $0.245B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.217B 0.00
Sutro Biopharma (STRO) United States $0.216B 0.00
Albireo Pharma (ALBO) United States $0.215B 0.00
Seres Therapeutics (MCRB) United States $0.214B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.212B 0.00
Inovio Pharmaceuticals (INO) United States $0.211B 0.00
Compugen (CGEN) Israel $0.206B 0.00
Sorrento Therapeutics (SRNE) United States $0.206B 0.00
Athersys (ATHX) United States $0.205B 0.00
Exicure (XCUR) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.77
Spero Therapeutics (SPRO) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.186B 5.45
ChromaDex (CDXC) United States $0.182B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Dyadic (DYAI) United States $0.173B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.173B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.172B 0.00
Clovis Oncology (CLVS) United States $0.171B 0.00
Affimed (AFMD) Germany $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.158B 0.00
XOMA (XOMA) United States $0.156B 0.00
Alcobra (ARCT) United States $0.151B 0.00
Senesco Technologies (ELOX) United States $0.151B 0.00
Cerecor (CERC) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
Arsanis (XFOR) United States $0.144B 0.00
BioTime (LCTX) United States $0.139B 9.30
Northwest Biotherapeutics (NWBO) United States $0.136B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
CorMedix Inc (CRMD) United States $0.126B 0.00
NantKwest (NK) United States $0.118B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Acorda Therapeutics (ACOR) United States $0.115B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Novavax (NVAX) United States $0.112B 0.00
Menlo Therapeutics (MNLO) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.107B 4.40
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Emmaus Life Sciences (EMMA) United States $0.107B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.107B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.098B 0.00
Aptinyx (APTX) United States $0.095B 0.00
OvaScience (MLND) United States $0.095B 0.00
Trevena (TRVN) United States $0.091B 0.00
VBI Vaccines (VBIV) United States $0.090B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Fortress Biotech (FBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.081B 0.00
ARAVIVE, INC (ARAV) United States $0.080B 0.00
Aduro Biotech (ADRO) United States $0.079B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Mersana Therapeutics (MRSN) United States $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.058B 21.06
Catabasis Pharmaceuticals (CATB) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Unum Therapeutics (UMRX) United States $0.045B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
VIVUS (VVUS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Proteostasis Therapeutics (PTI) United States $0.040B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.034B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Clearside Biomedical (CLSD) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
DiaMedica Therapeutics (DMAC) United States $0.026B 0.00
Protalix BioTherapeutics (PLX) Israel $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00